Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4Gastrointestinal 4CNS 3Genitourinary 2Tumor-Agnostic 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Breast 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 302Fluorouracil 296Oxaliplatin 269Bevacizumab 267Capecitabine 233Leucovorin 229pembrolizumab 215Irinotecan 185Cisplatin 142Cetuximab 142Nivolumab 131Paclitaxel 117130-nm albumin-bound paclitaxel 117Sorafenib 86Albumin-Bound Paclitaxel 75Docetaxel 65regorafenib 64atezolizumab 64IFL protocol 61Folfox protocol 61Trastuzumab 55Panitumumab 47durvalumab 46Ramucirumab 43Injections 43Sunitinib 41Drug Therapy 41Carboplatin 40trifluridine tipiracil drug combination 38lenvatinib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Drug Delivery Systems × Gastrointestinal × Clear all
NCT05899985 2026-04-06

MAGMAP

Ferronova Pty Ltd

Phase NA Active not recruiting
60 enrolled
Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT04192565 2024-09-19

A Prospective Investigation of the ColubrisMX ELS System

ColubrisMX

Phase NA Completed
10 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01078415 2016-11-08

Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)

Angiodynamics, Inc.

Phase NA Completed
26 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01369420 2016-11-08

NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer

Angiodynamics, Inc.

Phase 2 Completed
10 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡